查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1936932

全球生物加工技術市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Bioprocess Technology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計生物加工技術市場將從 2025 年的 409.6 億美元成長到 2034 年的 879.5 億美元，2026 年至 2034 年的複合年成長率為 8.86%。

由於生物製藥需求不斷成長以及對高效生產製程的需求日益迫切，生物加工技術市場正經歷顯著成長。生物加工技術是指用於開發和生產生物製品（例如疫苗、單株抗體和重組蛋白）的一系列技術。隨著全球生物製藥產業的持續擴張，對能夠提高生產效率和降低成本的先進生物加工解決方案的需求也日益成長。隨著企業增加對生物加工技術的投資以提高生產效率和產品質量，預計該市場將穩步成長。

此外，生物加工技術的進步正在推動市場創新。連續生產流程、一次性技術和自動化解決方案的發展正在改變生物製藥的生產方式。這些創新不僅提高了效率，還降低了污染風險，並增強了可擴展性。隨著生物加工技術市場的不斷發展，持續的研發工作將在拓展解決方案範圍、滿足生物製藥產業多樣化需求方面發揮關鍵作用。

此外，對個人化醫療和標靶治療日益成長的關注也在塑造生物加工技術的發展趨勢。隨著醫療機構為每位患者尋求更個人化的治療方案，對靈活且適應性強的生物加工解決方案的需求預計將進一步成長。這一趨勢在細胞和基因治療領域尤其重要，因為該領域需要先進的生物製程技術來生產客製化的生物製品。隨著生物加工技術市場的持續成長，技術進步、監管合規以及對個人化醫療的追求三者融合，將在塑造其未來發展軌跡方面發揮關鍵作用，確保生物製藥公司能夠滿足不斷變化的醫療保健環境的需求。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球生物製程技術市場（依產品分類）

  • 市場分析、洞察與預測
  • 耗材及配件（培養基、試劑等）
  • 設備（生物製程分析儀、血液氣體分析儀、滲透壓計、細胞計數器、培養箱、生物反應器、其他（離心機、光強度、過濾設備））

5. 全球生物程序技術市場（按應用分類）

  • 市場分析、洞察與預測
  • 初次手術
  • 抗生素
  • 重組蛋白
  • 單株抗體
  • 生物相似藥

6. 全球生物程序技術市場（依最終用戶分類）

  • 市場分析、洞察與預測
  • 生物製藥公司
  • 契約製造組織
  • CRO（受託研究機構）
  • 食品和飼料業
  • 學術研究機構

7. 全球生物程序技術市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Siemens Healthineers
    • GE Healthcare
    • Sartorius AG
    • Becton, Dickinson And Company
    • Danaher Corporation
    • Eppendorf AG
    • Lonza
    • Advanced Instruments
    • Nova Biomedical
    • F. Hoffmann-La Roche Ltd
簡介目錄
Product Code: VMR11213676

The Bioprocess Technology Market size is expected to reach USD 87.95 Billion in 2034 from USD 40.96 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The bioprocess technology market is experiencing significant growth, driven by the increasing demand for biopharmaceuticals and the need for efficient production processes. Bioprocess technology encompasses a range of techniques used to develop and manufacture biological products, including vaccines, monoclonal antibodies, and recombinant proteins. As the global biopharmaceutical industry continues to expand, the demand for advanced bioprocessing solutions that enhance productivity and reduce costs is on the rise. Companies are increasingly investing in bioprocess technology to streamline their manufacturing operations and improve product quality, positioning this market for robust expansion.

Moreover, advancements in bioprocess technology are driving innovation within the market. The development of continuous manufacturing processes, single-use technologies, and automation solutions is transforming the way biopharmaceuticals are produced. These innovations not only enhance efficiency but also reduce the risk of contamination and improve scalability. As the bioprocess technology market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of solutions available to meet the diverse needs of the biopharmaceutical industry.

Additionally, the growing emphasis on personalized medicine and targeted therapies is shaping the bioprocess technology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable bioprocessing solutions is likely to rise. This trend is particularly relevant in the context of cell and gene therapies, where the production of customized biological products requires advanced bioprocessing techniques. As the bioprocess technology market continues to grow, the convergence of technological advancements, regulatory compliance, and the push for personalized medicine will play a pivotal role in shaping its future trajectory, ensuring that biopharmaceutical companies can meet the evolving demands of the healthcare landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Consumables & Accessories (Culture Media, Reagents, Others)
  • Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration))

By Application

  • Primary Surgical
  • Antibiotics
  • Recombinant Proteins
  • Monoclonal Antibodies
  • Biosimilar

By End-user

  • Biopharmaceutical Companies
  • Contract Manufacturing Organization
  • Contract Research Organization
  • Food & Feed Industry
  • Academic Research Organization

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, Siemens Healthineers, GE Healthcare, Sartorius AG, Becton, Dickinson And Company, Danaher Corporation, Eppendorf AG, Lonza, Advanced Instruments, Nova Biomedical, F HoffmannLa Roche Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Consumables & Accessories (Culture Media, Reagents, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration)) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Primary Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Biosimilar Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Contract Manufacturing Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Food & Feed Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Academic Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPROCESS TECHNOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Thermo Fisher Scientific Inc
    • 9.2.2 Siemens Healthineers
    • 9.2.3 GE Healthcare
    • 9.2.4 Sartorius AG
    • 9.2.5 Becton, Dickinson And Company
    • 9.2.6 Danaher Corporation
    • 9.2.7 Eppendorf AG
    • 9.2.8 Lonza
    • 9.2.9 Advanced Instruments
    • 9.2.10 Nova Biomedical
    • 9.2.11 F. Hoffmann-La Roche Ltd